Research Article
Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells
Table 1
Relationships between BMPER expression and clinicopathological characteristics of 94 patients with epithelial ovarian cancer.
| Characteristics | | Low | High | High expression rate (%) | | (-) | (+) | (++) | (+++) |
| FIGO stage | | | | | | | >0.05 | I-II | 41 | 4 | 9 | 8 | 20 | 68.29 | | III-IV | 53 | 6 | 5 | 14 | 24 | 71.70 | | Differentiation | | | | | | | >0.05 | Well-moderate | 49 | 5 | 9 | 12 | 23 | 71.43 | | Poor | 45 | 4 | 9 | 11 | 21 | 71.11 | | Pathologic type | | | | | | | >0.05 | Serous | 59 | 7 | 12 | 12 | 28 | 67.80 | | Mucinous | 10 | 2 | 1 | 3 | 4 | 70.00 | | Endometrioid | 17 | 0 | 4 | 2 | 11 | 76.47 | | Clear cell carcinoma | 8 | 0 | 1 | 3 | 4 | 87.50 | | LN metastasis | | | | | | | 0.044 | No | 56 | 6 | 14 | 14 | 22 | 64.29 | | Yes | 23 | 1 | 2 | 5 | 15 | 86.96 | | No lymphadenectomy | 15 | 2 | 2 | 3 | 8 | 73.33 | |
|
|
|